News

LifeScan launches diabetes awareness media campaign targeting the Hispanic community

Back

Media Tour, Backgrounders and Medical Experts Focused On Increasing Access to Essential Facts and Information about Diabetes Management and Blood Glucose Monitoring

Milpitas, CA - Oct. 13, 2005 - LifeScan, Inc., a Johnson & Johnson company and the maker of OneTouch® Ultra® Blood Glucose Monitoring System, today launched a three-city media tour as part of a national news media campaign targeting the Hispanic community with facts and information about the importance of diabetes management and blood glucose monitoring.

Statistics from the U.S. Centers for Disease Control and Prevention and the National Institutes of Health show that Hispanics are at a higher risk of developing and dying from diabetes, and twice as likely as other populations to experience complications such as heart disease, high blood pressure, blindness, kidney disease, amputations and nerve damage.

About 2 million Hispanics in the U.S. age 20 or older have been diagnosed with diabetes, which is the 6th leading cause of death among Hispanics. In addition, the prevalence of type 2 diabetes is 1.5 times higher in Hispanics than non-Hispanic whites.

"A lot of recent media coverage has focused on generating awareness about the growing diabetes epidemic within the Hispanic community," said, Jeff Christensen, Communications Manager at LifeScan. "Our goal is to provide information about diabetes management to those in the Hispanic community already struggling with this disease-information on diabetes management skills and things like blood glucose testing and its relationship to diet, medication and physical activity."

Impetus for this campaign comes from the ongoing need to provide in-language information to Hispanics as well as a recent study by the American Association of Clinical Endocrinologists, which studied 157,000 people in the U.S. with type 2 diabetes and found that 2/3 of them have blood glucose levels that are out of control . While diabetes can result in serious complications if not managed properly, research shows that when people with diabetes test and control their blood glucose levels, they can reduce their risk of eye, nerve and kidney damage by as much as 60 percent.

In addition to the three-city media tour, for which medical experts will be available in Chicago, Los Angeles and Miami for media interviews, outreach will be conducted in other Hispanic markets in the U.S. LifeScan will distribute articles bylined by diabetes experts and bilingual backgrounders on diabetes-related topics to the news media, offer healthcare professionals for radio, TV and print interviews, and provide other support for Hispanic media seeking to develop editorial stories on this topic.

LifeScan also participates in a number of local health fairs and community events, working closely with diabetes health educators that serve the Hispanic community. In addition, the company features an informative, Spanish-language Web site with in-language resources for individuals seeking information at www.OneTouchEnEspañol.com and maintains a Spanish-language telephone customer service line at 1 800 381-7226. "At LifeScan, we're committed to creating a world without limits for people with diabetes, and the first step is to give folks the knowledge to help them get there," said Christensen.

About LifeScan
LifeScan, Inc., a Johnson & Johnson company and the maker of OneTouch® Brand Blood Glucose Monitoring Systems, is committed to creating a world without limits for people with diabetes by providing fast, accurate, and easy-to-use products. LifeScan participates in health fairs and works closely with diabetes health educators, community- based organizations and the news media to educate the Hispanic community about the importance of effective diabetes management. LifeScan has bilingual operators available to answer questions at 1 800 381-7226 and a Spanish-language consumer Web site at www.OneTouchEnEspañol.com.

Back